Results 121 to 130 of about 282,905 (203)

FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. [PDF]

RNA Biol
Moriyama H, Moriyama S, Yokota T.
europepmc   +1 more source

Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov. [PDF]

Front Med (Lausanne)
Ashour AM.
europepmc   +1 more source

Washington 4-H projects: extension agents' guide to project selection and printed materials

, 1965
Washington State University Extension
core  

Poultry pointers available from your county extension agents office

, 1956
State College of Washington Extension Service
core  

Embodied Intelligence Applications in Health Care Populations: Scoping Review. [PDF]

J Med Internet Res
Shu W, Zhou Y, Sun E, Deng L, Ye X.
europepmc   +1 more source

Faricimab for choroidal neovascular membrane secondary to choroidal osteoma: A case report. [PDF]

J Int Med Res
Al Adel F, Alnfaiei JS, Alzahrani AA, Alotaibi WN.   +3 more
europepmc   +1 more source

Forage testing program of Washington State University (a manual for County Extension agents)

, 1960
Washington State University Extension
core  

Interleukin-23 Inhibitors in Inflammatory Bowel Disease. [PDF]

BioDrugs
Puca P, Parello S, Colantuono S, Tursi A, Coppola G, Lopetuso LR, Scaldaferri F, Gasbarrini A, Papa A.   +8 more
europepmc   +1 more source

The Impact of Targeted Therapies on the Bone-Vascular Axis in Psoriasis: A Narrative Review. [PDF]

Clin Cosmet Investig Dermatol
Zeng H, Chen Y, Yang L.
europepmc   +1 more source